György Sölétormos

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers

Catharine M. Sturgeon, Michael J. Duffy, Ulf‐Håkan Stenman et al. · Clinical Chemistry · 2008 · 1.1K citations

Medicine, Oncology, Urology +17

CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use

Michael J. Duffy, J. M. G. Bonfrer, J Kulpa et al. · International Journal of Gynecological Cancer · 2005 · 297 citations

Medicine, Gynecology, Oncology +17

Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer

György Sölétormos, Michael J. Duffy, Suher Othman Abu Hassan et al. · International Journal of Gynecological Cancer · 2015 · 263 citations · Full text

Medicine, Gynecology, Oncology +14

Abnormal vital signs are strong predictors for intensive care unit admission and in-hospital mortality in adults triaged in the emergency department - a prospective cohort study

Charlotte Barfod, Marlene Mauson Pankoke Lauritzen, Jakob Danker et al. · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · 2012 · 196 citations · Full text

Medicine, Emergency Medicine, Acute Care Medicine +13

Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy

Malgorzata Tuxen, György Sölétormos, P Dombernowsky · British Journal of Cancer · 2001 · 67 citations · Full text

Medicine, Gynecology, Oncology +16